Peptidome analysis of human skim milk in term and preterm milk

Biochemical and Biophysical Research Communications

Volumn 438, Issue 1, 2013, Pages 236-241

  Wan, Jun ^a   Cui, Xian wei ^a   Zhang, Jun ^b   Fu, Zi yi ^a   Guo, Xi rong ^a,c   Sun, Li Zhou ^d   Ji, Chen bo ^a  

^a WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Human milk; Isotope dimethyl labeling; Mass spectrometry; Peptidomics; Ultrafiltration

Indexed keywords

MILK PROTEIN; PROTEINASE;

ARTICLE; BREAST MILK; GESTATION PERIOD; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDOMICS; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCIENTIST;

HUMAN MILK; ISOTOPE DIMETHYL LABELING; MASS SPECTROMETRY; PEPTIDOMICS; ULTRAFILTRATION;

CHROMATOGRAPHY, LIQUID; HUMANS; MILK PROTEINS; MILK, HUMAN; PEPTIDOMIMETICS; PREMATURE BIRTH; PROTEOME; TANDEM MASS SPECTROMETRY; ULTRACENTRIFUGATION;

EID: 84881545253     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.068     Document Type: Article

References (35)

1. Adermann K., John H., Standker L., Forssmann W.G. Exploiting natural peptide diversity: novel research tools and drug leads. Curr. Opin. Biotechnol. 2004, 15:599-606.
2. S.A. Atkinson, Effects of gestational stage at delivery on human milk components, in Jensen, R. G (Eds). Handbook of Milk Composition, San Diego: Academic Press. (1995) 222-237.
3. Berven F.S., Kroksveen A.C., Berle M., Rajalahti T., Flikka K., Arneberg R., et al. Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. Proteomics-Clin. Appl. 2007, 1:699-711.
4. Bielicki J., Huch R., von Mandach U. Time-course of leptin levels in term and preterm human milk. Eur. J. Endocrinol. 2004, 151:271-276.
5. Boersema P.J., Raijmakers R., Lemeer S., Mohammed S., Heck A.J. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat. Protoc. 2009, 4:484-494.
6. Boire A., Covic L., Agarwal A., Jacques S., Sherifi S., Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005, 120:303-313.
7. Diamandis E.P. Peptidomics for cancer diagnosis: present and future. J. Proteome Res. 2006, 5:2079-2082.
8. Dvorak B., Fituch C.C., Williams C.S., Hurst N.M., Schanler R.J. Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr. Res. 2003, 54:15-19.
9. Geho D.H., Liotta L.A., Petricoin E.F., Zhao W., Araujo R.P. The amplified peptidome: the new treasure chest of candidate biomarkers. Curr. Opin. Chem. Biol. 2006, 10:50-55.
10. Grosvenor C.E., Picciano M.F., Baumrucker C.R. Hormones and growth factors in milk. Endocr. Rev. 1993, 14:710-728.
11. Huang H.L., Stasyk T., Morandell S., Mogg M., Schreiber M., Feuerstein I., et al. Enrichment of low-abundant serum proteins by albumin/immunoglobulin G immunoaffinity depletion under partly denaturing conditions. Electrophoresis 2005, 26:2843-2849.
12. Innis S.M. Human milk: maternal dietary lipids and infant development. Proc. Nutr. Soc. 2007, 66:397-404.
13. Ivanov V.T., Yatskin O.N. Peptidomics: a logical sequel to proteomics. Expert Rev. Proteomics 2005, 2:463-473.
14. Schulz-Knappe P., Zucht H.D., Heine G., Jürgens M., Hess R., Schrader M. Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb. Chem. High Throughput Screen. 2001, 4:207-217.
15. Soloviev M., Finch P. Peptidomics: bridging the gap between proteome and metabolome. Proteomics 2006, 6:744-747.
16. Adermann K., John H., Ständker L., Forssmann W.G. Exploiting natural peptide diversity: novel research tools and drug leads. Curr. Opin. Biotechnol. 2004, 15:599-606.
17. Geho D.H., Liotta L.A., Petricoin E.F., Zhao W., Araujo R.P. The amplified peptidome: the new treasure chest of candidate biomarkers. Curr. Opin. Chem. Biol. 2006, 10:50-55.
18. Wulfkuhle J.D., Liotta L.A., Petricoin E.F. Proteomic applications for the early detection of cancer. Nat. Rev. Cancer 2003, 3:267-275.
19. Matrisian L.M., Sledge G.J., Mohla S. Extracellular proteolysis and cancer: meeting summary and future directions. Cancer Res. 2003, 63:6105-6109.
20. Merrell K., Southwick K., Graves S.W., Esplin M.S., Lewis N.E., Thulin C.D. Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry. J. Biomol. Tech. 2004, 15:238-248.
21. Villanueva J., Philip J., DeNoyer L., Tempst P. Data analysis of assorted serum peptidome profiles. Nat. Protoc. 2007, 2:588-602.
22. Mian S., Ugurel S., Parkinson E., Schlenzka I., Dryden I., Lancashire L., et al. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. J. Clin. Oncol. 2005, 23:5088-5093.
23. Montagne P., Cuilliere M.L., Mole C., Bene M.C., Faure G. Immunological and nutritional composition of human milk in relation to prematurity and mother's parity during the first 2weeks of lactation. J. Pediatr. Gastroenterol. Nutr. 1999, 29:75-80.
24. Murakami M., Dorschner R.A., Stern L.J., Lin K.H., Gallo R.L. Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr. Res. 2005, 57:10-15.
25. Hsu J.L., Huang S.Y., Chow N.H., Chen S.H. Stable-isotope dimethyl labeling for quantitative proteomics. Anal. Chem. 2003, 75:6843-6852.
26. Owen C.G., Whincup P.H., Kaye S.J., Martin R.M., Davey S.G., Cook D.G., et al. Does initial breastfeeding lead to lower blood cholesterol in adult life? A quantitative review of the evidence. Am. J. Clin. Nutr. 2008, 88:305-314.
27. Robbins R.J., Villanueva J., Tempst P. Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?. J. Clin. Oncol. 2005, 23:4835-4837.
28. Sgarbieri V.C. Propriedades fisiológicas-funcionais das proteínas do soro de leite. Rev. Nutr. 2004, 17:397-409.
29. Shores K.S., Knapp D.R. Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis. J. Proteome Res. 2007, 6:3739-3751.
30. Soloviev M., Finch P. Peptidomics: bridging the gap between proteome and metabolome. Proteomics 2006, 6:744-747.
31. Srinivasan M., Patel M.S. Metabolic programming in the immediate postnatal period. Trends Endocrinol. Metab. 2008, 19:146-152.
32. Tirumalai R.S., Chan K.C., Prieto D.A., Issaq H.J., Conrads T.P., Veenstra T.D. Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2003, 2:1096-1103.
33. Villanueva J., Martorella A.J., Lawlor K., Philip J., Fleisher M., Robbins R.J., et al. Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol. Cell. Proteomics 2006, 5:1840-1852.
34. Villanueva J., Shaffer D.R., Philip J., Chaparro C.A., Erdjument-Bromage H., Olshen A.B., et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest. 2006, 116:271-284.
35. Zheng X., Baker H., Hancock W.S. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J. Chromatogr. A 2006, 1120:173-184.